/PRNewswire/ Dr. Antoni Ribas, an immuno-oncology pioneer, has joined Vial s Oncology Scientific Advisory Board. Dr. Ribas, along with other members of the.
/PRNewswire/ Dr. Antoni Ribas, an immuno-oncology pioneer, has joined Vial s Oncology Scientific Advisory Board. Dr. Ribas, along with other members of the.
/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid.
/PRNewswire/ Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects,.